Published in Am J Surg on January 01, 1996
Tumour markers of prognosis in colorectal cancer. Br J Cancer (1999) 1.68
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist (2010) 1.26
Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer. Cancer Res (2009) 1.10
Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci (2012) 1.07
Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev (2006) 0.94
Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer. Br J Cancer (1998) 0.91
What we could do now: molecular pathology of colorectal cancer. Mol Pathol (2001) 0.88
p53 protein accumulation as a prognostic marker in sporadic colorectal cancer. Int J Colorectal Dis (2006) 0.85
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer (1998) 0.82
Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions. Oncotarget (2016) 0.81
Genetic prognostic markers in colorectal cancer. Mol Pathol (1997) 0.79
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma. Oncol Lett (2016) 0.76
KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget (2017) 0.75
Detection of p53 gene mutations by nonisotopic RNase cleavage assay as a predictor of poor prognosis in colorectal cancers. Dig Dis Sci (2003) 0.75
A model for three-point analysis of random general transduction. Genetics (1966) 16.23
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med (1970) 9.83
An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (1994) 8.60
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (1985) 7.54
A common precursor for hematopoietic and endothelial cells. Development (1998) 6.58
Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol (2000) 5.53
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev (1994) 5.22
Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development (1999) 4.93
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol (1990) 3.53
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development (1991) 2.90
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate (2000) 2.79
A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature (1997) 2.78
Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells. Nat Genet (1992) 2.66
Ferrous-activated nicotinamide adenine dinucleotide-linked dehydrogenase from a mutant of Escherichia coli capable of growth on 1, 2-propanediol. J Bacteriol (1969) 2.66
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol (1992) 2.54
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development (1997) 2.32
Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol (2001) 2.30
Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J Virol (2001) 2.28
Mutants of Aerobacter aerogenes capable of utilizing xylitol as a novel carbon. J Bacteriol (1968) 2.28
The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus. Mol Cell (1998) 2.22
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. Nature (1983) 2.20
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Purification and properties of lactaldehyde dehydrogenase from Escherichia coli. J Biol Chem (1969) 2.11
Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol (2001) 2.03
Clonal fluctuation within the haematopoietic system of mice reconstituted with retrovirus-infected stem cells. EMBO J (1987) 2.02
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93
Variable region genes for the immunoglobulin framework are assembled from small segments of DNA--a hypothesis. Proc Natl Acad Sci U S A (1978) 1.92
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells. Diabetologia (2011) 1.87
A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development (2000) 1.86
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann N Y Acad Sci (1971) 1.84
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis. Virology (1992) 1.77
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana. Planta (2000) 1.68
INS(GFP/w) human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells. Diabetologia (2011) 1.68
Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit Care Med (2000) 1.66
Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer (1993) 1.66
Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol (2001) 1.66
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol (2001) 1.61
Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg (1996) 1.60
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol (1999) 1.55
The role of laparoscopy in preoperative staging of esophageal cancer. Surg Endosc (2000) 1.49
Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology (1990) 1.49
Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J Biol Chem (1977) 1.48
Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem (1995) 1.48
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Promoter sequences required for function of the human gamma globin gene in erythroid cells. EMBO J (1986) 1.47
Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol (2001) 1.46
Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol (1997) 1.46
Kabat Database and its applications: future directions. Nucleic Acids Res (2001) 1.45
Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res (2001) 1.45
Emergency abdominal wall reconstruction with polypropylene mesh: short-term benefits versus long-term complications. Ann Surg (1981) 1.44
Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol (2000) 1.44
Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol (1995) 1.41
Salutary effects of ATP-MgCl2 on the depressed endothelium-dependent relaxation during hyperdynamic sepsis. Crit Care Med (1999) 1.40
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Clinical decision-making in early breast cancer. Ann Surg (1993) 1.39
Inactivation of lipid-containing viruses by long-chain alcohols. Antimicrob Agents Chemother (1977) 1.39
Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol (2001) 1.39
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Br J Cancer (2010) 1.38
Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality. Am J Surg (1980) 1.38
Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36
Kabat database and its applications: 30 years after the first variability plot. Nucleic Acids Res (2000) 1.36
The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res (1990) 1.36
In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology (1989) 1.34
Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg (1988) 1.34
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine (2001) 1.31
Composite predictions of secondary structures of lac repressor. Biopolymers (1979) 1.31
DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods (2001) 1.30
MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J (2000) 1.30
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
Dispersal barriers in tropical oceans and speciation in Atlantic and eastern Pacific sea urchins of the genus Echinometra. Mol Ecol (2000) 1.29
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Gene transfer into murine stem cells and mice using retroviral vectors. Cold Spring Harb Symp Quant Biol (1985) 1.27
Nucleotide sequence stability of the genome of hepatitis delta virus. J Virol (1995) 1.27
Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J Exp Med (2001) 1.26
Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut (2005) 1.24
Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney. Ann Surg (1993) 1.24
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol (1997) 1.24